# Keratoacanthoma-like eruption associated with pembrolizumab and dupilumab treated by intralesional triamcinolone: A case report

**Authors:** Raphaella Lambert, Elizabeth Rotrosen, Hannah Verma, Grace Rabinowitz, Patricia Heller, Nicholas Gulati

PMC · DOI: 10.1016/j.jdcr.2025.03.036 · 2025-04-26

## Full-text entities

- **Diseases:** Keratoacanthoma (MESH:D007636), like (MESH:C537419), eruption (MESH:D003875)
- **Chemicals:** triamcinolone (MESH:D014221), dupilumab (MESH:C582203), pembrolizumab (MESH:C582435)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12173705/full.md

---
Source: https://tomesphere.com/paper/PMC12173705